163 related articles for article (PubMed ID: 36069079)
1. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
Tıskaoğlu NS; Yazıcı A
Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
[TBL] [Abstract][Full Text] [Related]
2. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
Tıskaoğlu NS; Yazıcı A
Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
[TBL] [Abstract][Full Text] [Related]
3. Tear-Film Osmolarity Changes Following Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
Yuksel N; Akcay E; Ayan B; Duru N
Curr Eye Res; 2017 Mar; 42(3):348-350. PubMed ID: 27419611
[TBL] [Abstract][Full Text] [Related]
4. Meibomian Gland Dysfunction in Primary Acquired Nasolacrimal Duct Obstruction.
Yoon S; Lee H; Baek S
J Craniofac Surg; 2023 Jun; 34(4):e395-e398. PubMed ID: 37157128
[TBL] [Abstract][Full Text] [Related]
5. Dry Eye Assessment of Patients Undergoing Endoscopic Dacryocystorhinostomy for Nasolacrimal Duct Obstruction Combined with Dry Eye Syndrome.
Kim MH; Lee K; Chang M
Korean J Ophthalmol; 2023 Oct; 37(5):395-400. PubMed ID: 37621092
[TBL] [Abstract][Full Text] [Related]
6. Changes in the meibomian glands in postmenopausal women with primary acquired nasolacrimal duct obstruction: a prospective study.
Jin H; Zhang H
BMC Ophthalmol; 2023 Feb; 23(1):48. PubMed ID: 36726065
[TBL] [Abstract][Full Text] [Related]
7. Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.
Yazici A; Bulbul E; Yazici H; Sari E; Tiskaoglu N; Yanik B; Ermis S
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4425-9. PubMed ID: 26193918
[TBL] [Abstract][Full Text] [Related]
8. Videoreflective dacryomeniscometry in normal adults and in patients with functional or primary acquired nasolacrimal duct obstruction.
Francis IC; Chan DG; Papalkar D; Papas EB; Stapleton F
Am J Ophthalmol; 2005 Mar; 139(3):493-7. PubMed ID: 15767059
[TBL] [Abstract][Full Text] [Related]
9. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
Stahl U; Francis IC; Stapleton F
Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
[TBL] [Abstract][Full Text] [Related]
10. Lacrimal gland activity in lacrimal drainage obstruction: exploring the potential cross-talk between the tear secretion and outflow.
Singh S; Srivastav S; Bothra N; Paulsen F; Ali MJ
Br J Ophthalmol; 2024 Mar; 108(4):621-624. PubMed ID: 37142331
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinase-9 Point-of-Care Immunoassay after Dacryocystorhinostomy in Patients with Nasolacrimal Duct Obstruction.
Woo SE; Jang SY
Semin Ophthalmol; 2021 Apr; 36(3):128-131. PubMed ID: 33641609
[TBL] [Abstract][Full Text] [Related]
12. Tear protein analysis in patients with primary acquired nasolacrimal duct obstruction treated with lacrimal passage intubation.
Yaginuma S; Konno K; Shigeyasu C; Yamada M
Jpn J Ophthalmol; 2021 May; 65(3):409-415. PubMed ID: 33411097
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of dye disappearance test and tear meniscus height in diagnosis and postoperative assessment of nasolacrimal duct obstruction.
Roh JH; Chi MJ
Acta Ophthalmol; 2010 May; 88(3):e73-7. PubMed ID: 20546233
[TBL] [Abstract][Full Text] [Related]
14. Alteration of Tear Cytokine Expressions in Primary Acquired Nasolacrimal Duct Obstruction - Potential Insights into the Etiopathogenesis.
Ali MJ; Patnaik S; Kelkar N; Ali MH; Kaur I
Curr Eye Res; 2020 Apr; 45(4):435-439. PubMed ID: 31490706
[No Abstract] [Full Text] [Related]
15. Tear osmolarity and tear film parameters in patients with unilateral pterygium.
Ozsutcu M; Arslan B; Erdur SK; Gulkilik G; Kocabora SM; Muftuoglu O
Cornea; 2014 Nov; 33(11):1174-8. PubMed ID: 25255132
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
Yuksel N; Mutlu M; Kilicarslan A; Akcay E
Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
[TBL] [Abstract][Full Text] [Related]
17. Impairment of lacrimal secretion in the unaffected fellow eye of patients with recurrent unilateral herpetic keratitis.
M'Garrech M; Rousseau A; Kaswin G; Sauer A; Barreau E; Bourcier T; Labetoulle M
Ophthalmology; 2013 Oct; 120(10):1959-67. PubMed ID: 23664465
[TBL] [Abstract][Full Text] [Related]
18. Modified ocular surface disease index as a screening criteria for dry eye syndrome presenting after successful dacryocystorhinostomy.
Kang TS; Cho J; Kim J; Sung JY; Kim JM; Kim KN; Lee SB
PLoS One; 2021; 16(2):e0247168. PubMed ID: 33630920
[TBL] [Abstract][Full Text] [Related]
19. Associations between Serial Intravitreal Injections and Dry Eye.
Malmin A; Thomseth VM; Førland PT; Khan AZ; Hetland HB; Chen X; Haugen IK; Utheim TP; Forsaa VA
Ophthalmology; 2023 May; 130(5):509-515. PubMed ID: 36693594
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
